These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32674607)

  • 41. Primary acquired melanosis of the conjunctiva.
    Lin SM; Ferrucci S
    Optometry; 2006 May; 77(5):223-8. PubMed ID: 16651212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
    Frucht-Pery J; Pe'er J
    Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resolution of primary acquired melanosis with atypia after treatment with topical mitomycin C and interferon alfa-2b.
    Ghassemi F; Ghadimi H; Nikdel M
    J Ophthalmic Vis Res; 2015; 10(1):84-6. PubMed ID: 26005559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
    Yuen VH; Jordan DR; Brownstein S; Dorey MW
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):149-51. PubMed ID: 12644763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    Tunc M; Erbilen E
    Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
    Soto H; Bowen RC; Raval V; Yeaney G; Singh A
    Br J Ophthalmol; 2022 May; 106(5):605-609. PubMed ID: 33355161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Siganos CS; Kozobolis VP; Christodoulakis EV
    Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK; Ertoy D; Kalayci D; Hasiripi H
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of large conjunctival nevus by resection and reconstruction using amniotic membrane.
    Tomita M; Goto H; Muramatsu R; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):761-4. PubMed ID: 16315045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of corneo-conjunctival malignant melanoma with "no touch technique" surgical excision and corneoscleral lamellar keratoplasty].
    Chen JQ; Sun MX; Sha XY; Zhang P; Lin YS; Li H; Liu YM; Chen LS
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):22-6. PubMed ID: 16638276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
    Frucht-Pery J; Rozenman Y; Pe'er J
    Ophthalmology; 2002 Mar; 109(3):548-52. PubMed ID: 11874760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations.
    Rudkin AK; Muecke JS
    Clin Exp Ophthalmol; 2009 May; 37(4):352-6. PubMed ID: 19594560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delayed Onset Scleromalacia and Conjunctival Bleb Formation Following Intraoperative Mitomycin C Application during Conjunctival Melanoma Excision.
    Ahmed SN; Shahid SM; Nanavaty MA
    Vision (Basel); 2020 May; 4(2):. PubMed ID: 32384819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.